Mucormycosis: A Rare disease to Notifiable Disease-Reference-Cited by-同舟云学术

Mucormycosis: A Rare disease to Notifiable Disease

Published:2024-04-01 Issue:2 Volume:55 Page:1065-1081
ISSN:1517-8382
Container-title:Brazilian Journal of Microbiology
language:en
Short-container-title:Braz J Microbiol

Author:

Panda Sunita,Sahu Mahesh Chandra,Turuk Jyotirmayee^ORCID,Pati Sanghamitra

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s42770-024-01315-z.pdf

Reference112 articles.

1. World Health Organization. COVID-19 Weekly Epidemiological Update. World Heal Organ. 2022;(August):1–33. https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update

2. Bardi T, Pintado V, Gomez-Rojo M et al (2021) Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis 40(3):495–502. https://doi.org/10.1007/s10096-020-04142-w

3. Kumar M, Sarma DK, Shubham S et al (2021) Mucormycosis in COVID-19 pandemic: Risk factors and linkages. Curr Res Microb Sci 2:100057. https://doi.org/10.1016/j.crmicr.2021.100057

4. Rocha ICN, Hasan MM, Goyal S et al (2021) COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India. Trop Med Int Heal 26(9):1016–1018. https://doi.org/10.1111/tmi.13641

5. Prakash H, Chakrabarti A (2019) Global epidemiology of mucormycosis. J Fungi. 5(1). https://doi.org/10.3390/jof5010026

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro antifungal activity of MMV Pathogen Box® compounds alone or in combination with antifungal drugs against mucormycosis agents;Current Research in Microbial Sciences;2024